Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 145 for pancreatic cancer

Edit search filters
  1. A Study Of BBI608 Combined With Standard Chemotherapies In Adult Patients Who Have Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  2. Phase 2 Nab®-Paclitaxel (Abraxane®) Plus Gemcitabine In Subjects With Locally Advanced Pancreatic Cancer (LAPC)

    Scottsdale/Phoenix, AZ

  3. Study Assessing Safety And Efficacy Of Combination Of BL-8040 And Pembrolizumab In Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202)

    Scottsdale/Phoenix, AZ

  4. Nab-paclitaxel And Gemcitabine Vs Gemcitabine Alone As Adjuvant Therapy For Patients With Resected Pancreatic Cancer (The "Apact" Study)

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study Of Cabiralizumab Given With Nivolumab With And Without Chemotherapy In Patients With Advanced Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  6. A Study To Evaluate The Safety And Immunological Effect Of Pembrolizumab In Resectable Or Borderline Resectable Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  7. PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine In Subjects With Stage IV Untreated Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  8. A Study Of ACP-196 Alone And In Combination With Pembrolizumab In Subjects With Advanced Or Metastatic Pancreatic Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. 68GaFAPI-46 PET/CT For Pancreatic Ductal Adenocarcinoma

    Rochester, MN

  10. Pharmacokinetic And Safety Study Of Nab ®-Paclitaxel (ABI-007) Plus Gemcitabine In Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubenemia

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer